Search clinical trials for: antiplatelet drugs

Total 257372 results

Chinese Academy of Medical Sciences, Fuwai Hospital

Completed

A Single-center, Prospective,Randomized Study of Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Patients With Dual Anti-platelet Therapy After Coronary Artery Bypass Grafting (ATCCC)

Antiplatelet Therapy of Coronary Artery Bypass

China
University of Utah

Completed

Antiplatelet Activity of Aspirin in Infants After Aortopulmonary and Cavopulmonary Shunts

Congenital Heart Disease

United States
Kaiser Franz Josef Hospital

Completed

Individualizing Dual Antiplatelet Therapy After Percutaneous Coronary Intervention - The IDEAL-PCI Registry (IDEAL-PCI)

Coronary Stent Implantation | Platelet Inhibition

Austria
Tulane University School of Medicine
National Institute of Mental Health (NIMH)

Completed

Effect of D-cycloserine on Treatment of Posttraumatic Stress Disorder (PTSD) in Youth

PTSD | Posttraumatic Stress Disorders

United States
Christiana Care Health Services
United States Department of Defense

Terminated

Safety of Platelet Transfusion in Patients on Antiplatelet Therapy With Traumatic Head Injury (PUNCH)

Traumatic Head Injury | Intracranial Hemmorhage | Anti-platelet Therapy

United States
Beth Israel Deaconess Medical Center

Terminated

Role of Plavix in Hemorrhagic and Ischemic Complications of Catheterization.

Myocardial Ischemia | Coronary Artery Disease | Bleeding

United States
Chiang Mai University

Unknown

Continue vs. Stop P2Y12 Inhibitor on Bleeding in Patient Receiving DAPT Undergoing Dental Procedure.

Antiplatelet Agents | Dental Diseases | Antiplatelet Drugs
Hamilton Health Sciences Corporation

Unknown

Reversal of the Antiplatelet Effects of Ticagrelor in Combination With Aspirin, Using Normal Platelets (REVSTARTS)

Aspirin | Platelet Dysfunction Due to Drugs | Ticagrelor | Transfusion

Canada
AstraZeneca

Completed

Clinical Outcomes of Exenatide Versus Basal Insulin

Type 2 Diabetes

United Kingdom
Guangdong Provincial People's Hospital

Completed

The Impact of Genotype on Pharmacokinetics and Antiplatelet Effects of Ticagrelor in Healthy Chinese (IGPPT)

Healthy
The First Affiliated Hospital with Nanjing Medical...
National Natural Science Foundation of China

Unknown

Different Platelet Activities Between Intracoronary and Peripheral Blood in Coronary Artery Disease Patients (DPABIAP)

Coronary Artery Disease

China
AstraZeneca

Completed

Prevention of Cardiovascular Events by Antiplatelet Agents After Acute Coronary Syndrome (AReMIS)

Acute Coronary Syndrome

France
CHEOL WHAN LEE, M.D., Ph.D
Medtronic; CardioVascular Research Foundation, Korea; Chong Kun Dang Pharmaceutical...

Terminated

Short-Term Dual Antiplatelet and Maintenance CloPidogrel Therapy After Drug-Eluting Stent Implantation (STAMP-DES)

Coronary Artery Disease

Korea, Republic of
Georgetown University

Withdrawn

Evaluation of a Compliance Marker in Prescription Opioid Abusers With Chronic Pain

Chronic Pain | Compliance

United States
Yongjian Wu

Unknown

Evaluation of Antiplatelet Effects and Safety of Intraoperative Administration of Ticagrelor Versus Clopidogrel

Coronary Disease

China
Associations for Establishment of Evidence in Interventions

Completed

Nobori Dual Antiplatelet Therapy as Appropriate Duration

Coronary Artery Disease

Japan
Assistance Publique - Hôpitaux de Paris
Eli Lilly and Company; Daiichi Sankyo, Inc.; Stentys; Accumetrics, Inc.; Allies in...

Completed

Tailored Antiplatelet Therapy Versus Recommended Dose of Prasugrel (ANTARCTIC)

Acute Coronary Syndrome

France
Johns Hopkins University

Completed

Pharmacogenomics of Antiplatelet Response - II (PARes-II) (PARes-II)

Atherothrombosis

United States
Johns Hopkins University

Completed

Pharmacogenomics of Antiplatelet Response - I (PARes-I)

Coronary Artery Disease | Platelet Aggregation | Platelet Transcriptome

United States
Johns Hopkins University

Completed

Pharmacogenomics of Antiplatelet Response (PARes-III)

Atherosclerosis

United States
Assistance Publique Hopitaux De Marseille

Unknown

Registry of the Combination of Antiplatelet Agents and Anticoagulant in Atrial Fibrillation Patients With a CHA2DS2VASc Score >1 Undergoing Percutaneous Coronary Interventions

Percutaneous Coronary Intervention

France
Charite University, Berlin, Germany
Prof. Dr. Jochen Fiebach, Center for Stroke Research Berlin (CSB), Charité...

Unknown

Dual AntiPlatelet Therapies for Prevention of Periinterventional Embolic Events in TAVI (DAPT-TAVI)

Aortic Valve Stenosis | Transcatheter Aortic Valve Replacement | Intracranial Embolism
Yonsei University

Completed

Additional Benefit of Cilostazol to Dual Antiplatelet Therapy After Biolimus-eluting Stent Implantation (ABCD)

Coronary Artery Disease

Korea, Republic of
General Hospital of Chinese Armed Police Forces

Completed

Different LD of Ticagrelor for Antiplatelet Effect in Patients With Non-ST-segment Elevation ACS Undergoing PCI

Non ST Segment Elevation Acute Coronary Syndrome

China
Kangbuk Samsung Hospital
Asan Medical Center

Unknown

Effect of aSpirin Versus CilOstazol for Inhibition of Antiplatelet aggRegaTion in Type 2 DM Patients

Type 2 Diabetes Mellitus
Zealand University Hospital

Completed

Non-responders to Antiplatelet Treatment in Acute Ischaemic Stroke) (NATIS)

Acute Ischemic Stroke

Denmark
Lawson Health Research Institute

Completed

Effect of Ticagrelor on Endothelial Function

Coronary Artery Disease | Endothelial Function

Canada
GlaxoSmithKline

Completed

A Monotherapy Study to Evaluate the Efficacy and Safety of 2 Dose Levels of Albiglutide in Japanese Subjects With Type 2 Diabetes Mellitus (T2DM)

Diabetes Mellitus, Type 2

Japan
Johannes Gutenberg University Mainz

Completed

Endothelium, Stenting, and Antiplatelet Therapy (EST) - Clopidogrel, Prasugrel, Ticagrelor Study (EST)

Coronary Artery Disease

Germany
Incheon St.Mary's Hospital

Unknown

Polypectomy in Patients Taking Dual Antiplatelet Agents

Colonic Polyps

Korea, Republic of
Teikyo University

Unknown

3-Month Discontinuation of Dual Antiplatelet Therapy After Ultimaster Sirolimus-Eluting Stent Implantation (MODEL U-SES)

Coronary Artery Disease

Japan
David Antoniucci
A.R. CARD Onlus Foundation

Terminated

BLeeding Events and Maintenance DoSe of PraSugrel (BLESS)

Acute Coronary Syndrome | Adverse Reaction to Antiplatelet Agent

Italy
Tufts Medical Center
Dialysis Clinic, Inc.

Withdrawn

Evaluation of New Markers to Assess Kidney Function

Chronic Kidney Disease
Juan J Badimon
AstraZeneca

Completed

Antithrombotic Effects of Ticagrelor Versus Clopidogrel

Acute Coronary Syndrome

United States
Rabin Medical Center

Unknown

Is There a Transient Rebound Effect of Platelet Reactivity Following Cessation of Dual Antiplatelet Therapy With Ticagrelor - a Single Center Prospective Observational Trial

Platelet Reactivity | Dual Antiplatelet Therapy

Israel
Yong Huo

Completed

Arachidonic Acid-induced Platelet Aggregation Rate in Patients With Stable CAD Treated With Ticagrelor Monotherapy

Coronary Heart Disease

China
Beijing Jishuitan Hospital

Completed

Smart Nitinol Stent System for the Treatment of Severe Atherosclerotic Carotid Stenosis

Carotid Artery Stenosis
Taipei Veterans General Hospital, Taiwan

Unknown

Ticagrelor Versus Clopidogrel in Myocardial Salvage in Patients With STEMI Undergoing Primary PCI

Acute Coronary Syndrome

Taiwan
New York State Psychiatric Institute
National Institute of Mental Health (NIMH)

Completed

Treatment of Behavioral Symptoms in Alzheimer's Disease

Psychosis | Alzheimer's Disease | Agitation

United States
Elpen Pharmaceutical Co. Inc.

Completed

Antiplatelet Therapy Following Stent Implantation (Anti-Clot)

Angina, Unstable | Acute Myocardial Infarction | Coronary Syndrome

Greece
Assistance Publique - Hôpitaux de Paris
Action Research Group

Terminated

Acute Myocardial Necrosis and Depression: Antiplatelet Effect of Reuptake Inhibition of Serotonin (ANDROS)

Depression | Coronary Artery Disease

France
Seoul National University Bundang Hospital

Completed

Does Pantoprazole Reduce the Anti-platelet Effect of Clopidogrel?

Antiplatelet Effect

Korea, Republic of
Wuhan Asia Heart Hospital

Completed

High On-treatment Platelet Reactivity Identified by Multiple Platelet Function Assay (HOPEmultiPFA)

Acute Coronary Syndrome

China
Imam Abdulrahman Bin Faisal University
King Fahad Armed Forces Hospital; Dammam Central Hospital

Unknown

Bedside Testing of CYP2C19 Gene for Treatment of Patients With PCI With Antiplatelet Therapy

Myocardial Infarction | Infarction | Ischemia | Coronary Artery Disease | Cardiovascular Disease | Embolism | Thrombosis | Chest Pain | Angina Pectoris | Heart Disease | Vascular Disease

Saudi Arabia
University of Utah
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Electrophysiologic Study Versus Electrocardiographic Monitoring (ESVEM)

Heart Diseases | Cardiovascular Diseases | Arrhythmia | Ventricular Fibrillation | Tachycardia, Ventricular | Death, Sudden, Cardiac | Ventricular Arrhythmia
Medtronic Vascular

Completed

EDUCATE: The MEDTRONIC Endeavor Drug Eluting Stenting: Understanding Care, Antiplatelet Agents and Thrombotic Events (EDUCATE)

Coronary Artery Disease

United States
Beijing Anzhen Hospital

Unknown

The Application of Ticagrelor Combined With Low Molecular Weight Heparin During PCI

LOVASTATIN/TICAGRELOR [VA Drug Interaction]

China
AstraZeneca

Completed

REalWorld Insights on the INitiation and Treatment Duration of ticagrEloR & Other Oral Antiplatelets (OAP) in Patients With Acute Coronary Syndrome (ACS) in Be/Lux. (REWINDER)

Treatment of Acute Coronary Syndrome (ACS).

Belgium
Japan Cardiovascular Research Foundation

Unknown

Atrial Fibrillation and Ischemic Events With Rivaroxaban in Patients With Stable Coronary Artery Disease Study (AFIRE)

Atrial Fibrillation

Japan
Icahn School of Medicine at Mount Sinai
Daiichi Sankyo, Inc.; Accumetrics, Inc.

Completed

Patients Undergoing Percutaneous Coronary Intervention (PCI) Through Optimal Platelet Inhibition (TRIAGE)

Aspirin | Percutaneous Coronary Intervention | Dual Antiplatelet Therapy | Clopidogrel

United States

Search clinical trials for: antiplatelet drugs

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Macedonia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations